ScoreWhy is Wanbangde Pharmaceutical Holding Group Co., Ltd. ?
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -36.85% and Operating profit at -150.12% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 5.44% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -36.85% and Operating profit at -150.12% over the last 5 years
3
Flat results in Mar 26
- NET SALES(HY) At CNY 473.83 MM has Grown at -30.32%
- NET PROFIT(HY) At CNY -76.34 MM has Grown at -411.07%
- ROCE(HY) Lowest at -3%
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 84.16%, its profits have fallen by -418%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Wanbangde Pharmaceutical Holding Group Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Wanbangde Pharmaceutical Holding Group Co., Ltd.
81.86%
2.57
68.66%
China Shanghai Composite
21.43%
1.55
13.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-36.85%
EBIT Growth (5y)
-150.12%
EBIT to Interest (avg)
4.87
Debt to EBITDA (avg)
3.38
Net Debt to Equity (avg)
0.35
Sales to Capital Employed (avg)
0.38
Tax Ratio
39.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.71%
ROE (avg)
5.44%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.11
EV to EBIT
-697.46
EV to EBITDA
113.20
EV to Capital Employed
2.80
EV to Sales
7.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-0.40%
ROE (Latest)
-3.56%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 730.37 MM
NET SALES(Q)
At CNY 374.21 MM has Grown at 34.45%
RAW MATERIAL COST(Y)
Fallen by -114.26% (YoY
DEBT-EQUITY RATIO
(HY)
Lowest at 17.43 %
OPERATING PROFIT(Q)
Highest at CNY 138.8 MM
OPERATING PROFIT MARGIN(Q)
Highest at 37.09 %
PRE-TAX PROFIT(Q)
Highest at CNY 129.35 MM
NET PROFIT(Q)
Highest at CNY 102.95 MM
EPS(Q)
Highest at CNY 0.17
-18What is not working for the Company
NET SALES(HY)
At CNY 473.83 MM has Grown at -30.32%
NET PROFIT(HY)
At CNY -76.34 MM has Grown at -411.07%
ROCE(HY)
Lowest at -3%
INTEREST(Q)
At CNY 10.68 MM has Grown at 208.61%
Here's what is working for Wanbangde Pharmaceutical Holding Group Co., Ltd.
Pre-Tax Profit
At CNY 129.35 MM has Grown at 404.94%
over average net sales of the previous four periods of CNY -42.42 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 102.95 MM has Grown at 331.76%
over average net sales of the previous four periods of CNY -44.42 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
At CNY 374.21 MM has Grown at 34.45%
over average net sales of the previous four periods of CNY 278.33 MMMOJO Watch
Near term sales trend is very positive
Net Sales (CNY MM)
Operating Cash Flow
Highest at CNY 730.37 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Operating Profit
Highest at CNY 138.8 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 37.09 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 129.35 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY 102.95 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY 0.17
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Debt-Equity Ratio
Lowest at 17.43 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Raw Material Cost
Fallen by -114.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Wanbangde Pharmaceutical Holding Group Co., Ltd.
Interest
At CNY 10.68 MM has Grown at 208.61%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
